Institutional investors hold a majority ownership of CELG through the 82.34% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2017, these large investors purchased a net $7.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 4.7 Million shares of Celgene
STANDARD LIFE INVESTMENTS (USA) ... Bought 3.8 Million shares of Celgene
BANK OF AMERICA, NA (PRIVATE BAN... Bought 1.8 Million shares of Celgene